Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | INSM |
---|---|---|
09:32 ET | 30074 | 56.995 |
09:34 ET | 14155 | 56.77 |
09:36 ET | 20066 | 56.33 |
09:38 ET | 3152 | 56.25 |
09:39 ET | 7585 | 56.42 |
09:41 ET | 8819 | 56.34 |
09:43 ET | 3955 | 56.24 |
09:45 ET | 4474 | 56.235 |
09:48 ET | 3347 | 56.305 |
09:50 ET | 15740 | 56.17 |
09:52 ET | 3826 | 56.33 |
09:54 ET | 3096 | 56.62 |
09:56 ET | 7256 | 56.7052 |
09:57 ET | 5357 | 56.73 |
09:59 ET | 3399 | 56.79 |
10:01 ET | 5749 | 56.645 |
10:03 ET | 3228 | 56.65 |
10:06 ET | 2980 | 56.615 |
10:08 ET | 9277 | 56.725 |
10:10 ET | 4106 | 56.46 |
10:12 ET | 5152 | 56.34 |
10:14 ET | 4624 | 56.22 |
10:15 ET | 7523 | 56.62 |
10:17 ET | 1248 | 56.61 |
10:19 ET | 3207 | 56.74 |
10:21 ET | 621 | 56.7 |
10:24 ET | 1713 | 56.75 |
10:26 ET | 5665 | 56.53 |
10:28 ET | 2000 | 56.57 |
10:30 ET | 40893 | 56.51 |
10:32 ET | 4896 | 56.445 |
10:33 ET | 3374 | 56.67 |
10:35 ET | 2245 | 56.77 |
10:37 ET | 16074 | 57.08 |
10:39 ET | 2728 | 57.1 |
10:42 ET | 3372 | 57.09 |
10:44 ET | 5913 | 57.21 |
10:46 ET | 51657 | 57.4898 |
10:48 ET | 24008 | 57.72 |
10:50 ET | 11960 | 57.615 |
10:51 ET | 5609 | 57.87 |
10:53 ET | 7060 | 57.895 |
10:55 ET | 5218 | 57.83 |
10:57 ET | 8856 | 57.89 |
11:00 ET | 5831 | 57.97 |
11:02 ET | 5082 | 57.61 |
11:04 ET | 4309 | 57.535 |
11:06 ET | 8617 | 57.545 |
11:08 ET | 4107 | 57.67 |
11:09 ET | 40296 | 57.8199 |
11:11 ET | 1914 | 57.96 |
11:13 ET | 4587 | 57.82 |
11:15 ET | 1950 | 57.8749 |
11:18 ET | 2708 | 57.7 |
11:20 ET | 1553 | 57.7 |
11:22 ET | 3300 | 57.56 |
11:24 ET | 8207 | 57.7 |
11:26 ET | 12913 | 57.59 |
11:27 ET | 2099 | 57.84 |
11:29 ET | 2340 | 57.98 |
11:31 ET | 6812 | 57.865 |
11:33 ET | 4657 | 58.0419 |
11:36 ET | 38312 | 57.925 |
11:38 ET | 29904 | 57.845 |
11:40 ET | 4382 | 57.99 |
11:42 ET | 300 | 57.825 |
11:44 ET | 3466 | 57.825 |
11:45 ET | 1426 | 57.91 |
11:47 ET | 1200 | 57.82 |
11:49 ET | 300 | 57.89 |
11:51 ET | 5121 | 58.01 |
11:54 ET | 6162 | 58.0695 |
11:56 ET | 23464 | 58.35 |
11:58 ET | 9583 | 58.4 |
12:00 ET | 6599 | 58.4513 |
12:02 ET | 4122 | 58.435 |
12:03 ET | 11402 | 58.605 |
12:05 ET | 5899 | 58.575 |
12:07 ET | 10489 | 58.46 |
12:09 ET | 8334 | 58.435 |
12:12 ET | 5797 | 58.45 |
12:14 ET | 7413 | 58.455 |
12:16 ET | 6034 | 58.57 |
12:18 ET | 8090 | 58.62 |
12:20 ET | 4167 | 58.61 |
12:21 ET | 1873 | 58.56 |
12:23 ET | 4114 | 58.435 |
12:25 ET | 3313 | 58.46 |
12:27 ET | 871 | 58.5208 |
12:30 ET | 4200 | 58.53 |
12:32 ET | 300 | 58.51 |
12:34 ET | 10309 | 58.632 |
12:36 ET | 1705 | 58.565 |
12:38 ET | 1676 | 58.5349 |
12:39 ET | 1321 | 58.56 |
12:41 ET | 1700 | 58.525 |
12:43 ET | 8813 | 58.43 |
12:45 ET | 7652 | 58.6711 |
12:48 ET | 11704 | 58.765 |
12:50 ET | 10214 | 58.9 |
12:52 ET | 7750 | 58.9 |
12:54 ET | 90410 | 59.1 |
12:56 ET | 17525 | 59.11 |
12:57 ET | 9801 | 59.03 |
12:59 ET | 7678 | 59.11 |
01:01 ET | 5648 | 59.1 |
01:03 ET | 8125 | 58.9921 |
01:06 ET | 5368 | 59.14 |
01:08 ET | 11429 | 59.11 |
01:10 ET | 10424 | 59.27 |
01:12 ET | 3318 | 59.14 |
01:14 ET | 12396 | 59.18 |
01:15 ET | 4883 | 59.223 |
01:17 ET | 7118 | 59.17 |
01:19 ET | 2551 | 59.32 |
01:21 ET | 1800 | 59.41 |
01:24 ET | 13117 | 59.32 |
01:26 ET | 4306 | 59.36 |
01:28 ET | 5336 | 59.39 |
01:30 ET | 9938 | 59.285 |
01:32 ET | 14276 | 59.22 |
01:33 ET | 2877 | 59.02 |
01:35 ET | 12338 | 59.09 |
01:37 ET | 36611 | 59 |
01:39 ET | 1990 | 59 |
01:42 ET | 2606 | 59.03 |
01:44 ET | 3650 | 59.02 |
01:46 ET | 7617 | 59.3 |
01:48 ET | 1901 | 59.26 |
01:50 ET | 3298 | 59.19 |
01:51 ET | 900 | 59.225 |
01:53 ET | 2798 | 59.18 |
01:55 ET | 1671 | 59.16 |
01:57 ET | 2313 | 59.06 |
02:00 ET | 2333 | 59.12 |
02:02 ET | 4623 | 59.195 |
02:04 ET | 1298 | 59.14 |
02:06 ET | 83099 | 59.93 |
02:08 ET | 143622 | 60.1497 |
02:09 ET | 27088 | 60.05 |
02:11 ET | 33884 | 59.85 |
02:13 ET | 21671 | 59.76 |
02:15 ET | 14321 | 59.84 |
02:18 ET | 5585 | 59.72 |
02:20 ET | 2812 | 59.695 |
02:22 ET | 6149 | 59.7149 |
02:24 ET | 4323 | 59.63 |
02:26 ET | 11994 | 59.655 |
02:27 ET | 31349 | 59.63 |
02:29 ET | 12519 | 59.5399 |
02:31 ET | 7629 | 59.7045 |
02:33 ET | 4631 | 59.9 |
02:36 ET | 31565 | 59.9901 |
02:38 ET | 37831 | 59.98 |
02:40 ET | 7248 | 59.82 |
02:42 ET | 29531 | 59.94 |
02:44 ET | 16088 | 60.03 |
02:45 ET | 2235 | 59.92 |
02:47 ET | 15081 | 59.825 |
02:49 ET | 5336 | 59.91 |
02:51 ET | 10444 | 60.16 |
02:54 ET | 31901 | 60.1285 |
02:56 ET | 30216 | 59.84 |
02:58 ET | 26513 | 60.005 |
03:00 ET | 11332 | 60 |
03:02 ET | 4830 | 59.91 |
03:03 ET | 6000 | 59.6581 |
03:05 ET | 7046 | 59.68 |
03:07 ET | 15484 | 59.86 |
03:09 ET | 6052 | 59.94 |
03:12 ET | 9496 | 59.9519 |
03:14 ET | 8902 | 59.97 |
03:16 ET | 10107 | 60.0894 |
03:18 ET | 6219 | 60.1884 |
03:20 ET | 8499 | 60.21 |
03:21 ET | 15705 | 60.4 |
03:23 ET | 9061 | 60.4145 |
03:25 ET | 14018 | 60.5434 |
03:27 ET | 27038 | 60.46 |
03:30 ET | 5667 | 60.39 |
03:32 ET | 31722 | 60.54 |
03:34 ET | 30135 | 60.44 |
03:36 ET | 12949 | 60.52 |
03:38 ET | 15201 | 60.42 |
03:39 ET | 13507 | 60.415 |
03:41 ET | 10306 | 60.3601 |
03:43 ET | 10743 | 60.34 |
03:45 ET | 17722 | 60.46 |
03:48 ET | 22094 | 60.17 |
03:50 ET | 19045 | 59.98 |
03:52 ET | 71667 | 60.2432 |
03:54 ET | 32419 | 60.18 |
03:56 ET | 54368 | 59.71 |
03:57 ET | 48889 | 59.785 |
03:59 ET | 77231 | 59.9 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Insmed Inc | 9.3B | -11.4x | --- |
Ascendis Pharma A/S | 8.0B | -13.7x | --- |
Legend Biotech Corp | 8.3B | -17.5x | --- |
Intra-Cellular Therapies Inc | 7.2B | -59.9x | --- |
Blueprint Medicines Corp | 6.5B | -21.6x | --- |
Vaxcyte Inc | 7.7B | -17.0x | --- |
Insmed Incorporated is a global biopharmaceutical company. The Company's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its pipeline includes clinical-stage programs, brensocatib and TPIP, as well as other early-stage research programs. Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1), which is developing for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases, including chronic rhinosinusitis without nasal polyps (CRSsNP). TPIP is an inhaled formulation of the treprostinil prodrug treprostinil palmitil, which offers a differentiated product profile for pulmonary hypertension associated with interstitial lung disease (PH-ILD) and pulmonary arterial hypertension (PAH).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.3B |
---|---|
Revenue (TTM) | $315.5M |
Shares Outstanding | 163.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.14 |
EPS | $-5.23 |
Book Value | $-2.24 |
P/E Ratio | -11.4x |
Price/Sales (TTM) | 29.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -224.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.